Can a healthy diet reduce the risk of breast cancer recurrence?doi:10.1038/ncponc0945NoneNature Clinical Practice Oncology
"With this approval, we are redefining treatment options for a broader population of people impacted by breast cancer and facing the persistent risk of recurrence,” said Victor Bultó, President, US, Novartis. “We continue to transf...
Hormone-replacement therapy (HRT), which can be an effective treatment for menopausal symptoms, may slightly increase the risk of breast cancer or breast cancer recurrence. The risks depend on the type of HRT you’re taking, the dose you take, your age when you start taking it, and how lo...
Question:After I have completed my treatments for breast cancer, should I follow any special diet to reduce the risk of recurrence? Answer: There's not a lot of research with the role of nutrition after a diagnosis and after treatment for breast cancer. There is some research going on right...
SAN FRANCISCO — Women with breast cancer appear to live longer and have less chance of a cancer recurrence if they receive a paravertebral nerve block combined with general anesthesia during their cancer surgery, a study from Denmark has found. ...
In the process, consumption of animal products increases the risk for cardiovascular disease, cancer, diabetes, obesity, and other disorders. This dietary pattern also promotes the growth of unhealthful gut bacteria, fostering, among other things, the production of trimethylamine N-oxide, a ...
The GIM4 study looked at the effect of 2 to 3 years vs 5 years of letrozole on risk of recurrence in HR-positive early breast cancer. Treatment with 5 years of letrozole offered slightly better disease-free survival (DFS) than 2 to 3 years of therapy following 2 to 3 years of tamoxife...
the most common forms of menopausal hormone therapy treat symptoms well but increase the risk of breast cancer by a small amount [1]. Agents such as tamoxifen and aromatase inhibitors reduce breast cancer recurrence and incidence, but cause side effects, though dose reductions in tamoxifen have no...
The Perjeta-based regimen continued to reduce the risk of breast cancer recurrence or death versus Herceptin, chemotherapy and placebo, by 23% in the overall study population (iDFS, HR=0.77, 95% CI 0.66-0.91). More people who received post-surgery treatment with the Perjeta-based regimen remai...
网络减少……的危险;降低…的危险 网络释义 1. 减少……的危险 高三英语牛津Module10 Unit2... ... 3.account for 解释、占据 4.reduce the risk of减少……的危险2.permanent 永恒的、永远的 ... www.ewteacher.com|基于2个网页 2. 降低…的危险 ...